source
- Vistagen's anxiety nasal spray fails to outperform placebo in phase 2 trialVistagen Therapeutics reported that its experimental nasal spray fasedienol did not show a statistically significant advantage over placebo in a phase 2 study of social anxiety disorder. The trial…
- PacBio appoints COO Mark Van Oene as new CEO after Christian Henry steps downPacBio announced that its chief operating officer, Mark Van Oene, will become president and chief executive officer effective Aug. 5 and will join the company's board. Van Oene, who joined PacBio…